Maynard Um
-
-
-
-
-
-
-
EU approves Incyte's Opzelura cream for moderate atopic dermatitis
-
-
-
-
-
-
-
Incyte (INCY) PT Raised to $112 at BMO Capital
-
-
-
-
-
-
-
BMO Capital on Incyte (INCY): ''989 Updates Provide More Context to ET/MF Opportunity'
-
-
-
-
-
-
-
Incyte (INCY) Reiterated at Market Perform by Citizens Amid Positive Trial Results
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
-
-
-
-
-
-
-
Adagene partners with Incyte for cancer drug combination study
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
-
443,133 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

